U.S. News: City of Hope Is Best Cancer Hospital in the West

July 29, 2019 | Letisia Marquez

City of Hope has been named the best cancer hospital in the West by U.S. News & World Report’s 2019-20 Best Hospitals: Specialty Ranking. This marks the 13th consecutive year it has been distinguished as one of the nation’s elite cancer hospitals.

Continue Reading

New ‘liquid biopsy’ blood test could improve breast cancer diagnostics

August 7, 2019 | Letisia Marquez

Developed by TGen and partners, the test could help avoid unnecessary surgeries and enable physicians to continuously monitor cancer. It works by measuring tiny particles of tumor DNA circulating in a patient's bloodstream.

TGen study reveals osteosarcoma similarities in kids, dogs

July 19, 2019 | Samantha Bonar

City of Hope affiliate TGen and Tufts University's novel findings for this deadly bone cancer could lead to better treatments for people and pets.

Super cells could help doctors detect cancer seven years sooner

July 18, 2019 | Maxine Nunes

Tiny molecular "packages" can be harnessed for diagnosis and treatment of cancer, diabetes and other diseases, City of Hope researchers are discovering.

TGen IDs gene associated with most common liver cancer

April 19, 2019 | City of Hope

AKR1B10 could help provide early detection of hepatocellular carcinoma, and play a role in monitoring and treating this growing cause of cancer death.

Study explores why glioblastoma affects sexes differently

February 25, 2019 | City of Hope

A nationwide team of researchers that includes City of Hope’s Translational Genomics Research Institute (TGen) has identified molecular differences that explain why men die of glioblastoma, a type of brain cancer, at nearly twice the rate of women.

For this diabetes researcher, the mission is personal

December 5, 2018 | City of Hope

Sampath Rangasamy, Ph.D., a researcher at City of Hope affiliate TGen, has spent his whole life researching type 1 diabetes, a personal battle since he himself suffers from the disease.

Big data for better results: the power and the promise of precision medicine

September 26, 2018 | Sam Lazaryev

Jeff Trent, Ph.D., TGen president and research director, discusses the promise of precision medicine and his company’s exciting initiative with City of Hope.